Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Bladder cancer")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 3881

  • Page / 156
Export

Selection :

  • and

Does warfarin therapy influence the risk of bladder cancer?BLUMENTALS, William A; FOULIS, Philip R; SCHWARTZ, Skai W et al.Thrombosis and haemostasis. 2004, Vol 91, Num 4, pp 801-805, issn 0340-6245, 5 p.Article

Tissue specific expression and serum levels of human tissue factor in patients with urological cancerFÖRSTER, Yvonne; MEYE, Axel; ALBRECHT, Sybille et al.Cancer letters. 2003, Vol 193, Num 1, pp 65-73, issn 0304-3835, 9 p.Article

Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapyPOS, Floris J; KOEDOODER, Kees; HULSHOF, Maarten C. C. M et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 3, pp 835-841, issn 0360-3016, 7 p.Article

Radical cystectomy : Often too late?STÖCKLE, Michael; ALKEN, Peter; ENGELMANN, Udo et al.European urology. 2006, Vol 50, Num 6, pp 1132-1138, issn 0302-2838, 7 p.Article

Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesisHUSSEIN MOSTAFA KHALED; MAGDY SAYED ALY; MOKHTAR, Nadia et al.Urologic oncology. 2004, Vol 22, Num 6, pp 443-447, issn 1078-1439, 5 p.Article

Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene p53 (TP53) in patients with bladder cancerECKE, Thorsten H; LENK, Severin V; SCHLECHTE, Horst H et al.Anticancer research. 2003, Vol 23, Num 2A, pp 957-962, issn 0250-7005, 6 p.Conference Paper

RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapyHAGAN, Michael P; WINTER, Kathryn A; KAUFMAN, Donald S et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 3, pp 665-672, issn 0360-3016, 8 p.Article

Clinical radiobiology of stage T2-T3 bladder cancerMAJEWSKI, Wojciech; MACIEJEWSKI, Boguslaw; MAJEWSKI, Stanislaw et al.International journal of radiation oncology, biology, physics. 2004, Vol 60, Num 1, pp 60-70, issn 0360-3016, 11 p.Article

Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapyCOWAN, Richard A; MCBAIN, Catherine A; RYDER, W. David J et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 1, pp 197-207, issn 0360-3016, 11 p.Conference Paper

Concepts for banking tissue in urologic oncology-the international bladder cancer bankGOEBELL, Peter J; GROSHEN, Susan; COTE, Richard J et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 413-415, issn 1078-0432, 3 p., 1Article

Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancerCAFFO, Orazio; FELLIN, Gianni; GRAFFER, Umberto et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 5, pp 1310-1316, issn 0360-3016, 7 p.Article

Stage, grade and pathological characteristics of bladder cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour RegistryBOUSTEAD, Gregory B; FOWLER, Sarah; SWAMY, Rajiv et al.BJU international (Papier). 2014, Vol 113, Num 6, pp 924-930, issn 1464-4096, 7 p.Article

Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladderFEIL, Gerhard; ZUMBRÄGEL, Andreas; PÄULGEN-NELDE, Hans J et al.Anticancer research. 2003, Vol 23, Num 2A, pp 963-967, issn 0250-7005, 5 p.Conference Paper

Diagnosis of bladder cancer by analysis of urinary fibronectinMENENDEZ, Violeta; FERNANDEZ-SUAREZ, Antonio; GALAN, Juan Antonio et al.Urology (Ridgewood, NJ). 2005, Vol 65, Num 2, pp 284-289, issn 0090-4295, 6 p.Article

Down-regulation of S100C is associated with bladder cancer progression and poor survivalASHFAQUE AHMED MEMON; SORENSEN, Boe Sandahl; MELDGAARD, Peter et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 606-611, issn 1078-0432, 6 p., 1Article

Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancerPOS, Floris J; HORENBLAS, Simon; LEBESQUE, Joos et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 3, pp 696-705, issn 0360-3016, 10 p.Article

Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarkerMORGAN, Richard; BRYAN, Richard T; KNOWLES, Margaret A et al.European journal of cancer (1990). 2013, Vol 49, Num 9, pp 2214-2222, issn 0959-8049, 9 p.Article

New concepts of biobanks—strategic chance for uro-oncologyGOEBELL, Peter J; MORENTE, Manuel M.Urologic oncology. 2010, Vol 28, Num 4, pp 449-457, issn 1078-1439, 9 p.Conference Paper

Surgical benchmarks for the treatment of invasive bladder cancer : Setting benchmarks in the treatment of invasive bladder cancerSKINNER, Eila C; STEIN, John P; SKINNER, Donald G et al.Urologic oncology. 2007, Vol 25, Num 1, pp 66-71, issn 1078-1439, 6 p.Article

Cancer patient advocacy : New opportunities for treatment advancesZIPURSKY QUALE, Diane; DROLLER, Michael J.Urologic oncology. 2007, Vol 25, Num 4, pp 351-352, issn 1078-1439, 2 p.Conference Paper

Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: Results of a prospective Phase II Study : Bladder cancerWITJES, J. Alfred; MOONEN, Paula M. J; VAN DER HEIJDEN, Antoine G et al.European urology. 2005, Vol 47, Num 3, pp 319-322, issn 0302-2838, 4 p.Article

Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE)FEI LI; CHEN, Ding-Nan; LAN, Kai-Jian et al.Journal of proteomics (Print). 2012, Vol 77, pp 225-236, issn 1874-3919, 12 p.Article

BCAN Think Tank session 1: Overview of risks for and causes of bladder cancerZLOTTA, Alexandre R; COHEN, Samuel M; DINNEY, Colin et al.Urologic oncology. 2010, Vol 28, Num 3, pp 329-333, issn 1078-1439, 5 p.Conference Paper

Application of targeted radiotherapy/genetherapy to bladder cancer cell linesFULLERTON, Natasha E; MAIRS, Robert J; KIRK, David et al.European urology. 2005, Vol 47, Num 2, pp 250-256, issn 0302-2838, 7 p.Article

Deletions of chromosomes 9 and 8p in Histologically normal urothelium of patients with bladder cancerSTOEHR, Robert; ZIETZ, Sabrina; BURGER, Maximilian et al.European urology. 2005, Vol 47, Num 1, pp 58-63, issn 0302-2838, 6 p.Article

  • Page / 156